46916
芴甲氧羰酰胺
≥99.0% (HPLC)
别名:
Fmoc-酰胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C15H13NO2
化学文摘社编号:
分子量:
239.27
UNSPSC Code:
12352005
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
4188192
InChI
1S/C15H13NO2/c16-15(17)18-9-14-12-7-3-1-5-10(12)11-6-2-4-8-13(11)14/h1-8,14H,9H2,(H2,16,17)
SMILES string
NC(=O)OCC1c2ccccc2-c3ccccc13
InChI key
ZZOKVYOCRSMTSS-UHFFFAOYSA-N
assay
≥99.0% (HPLC)
form
solid
mp
201-204 °C
solubility
dioxane: 15 mg/mL, clear, colorless
application(s)
peptide synthesis
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Choi Yi Li et al.
Chembiochem : a European journal of chemical biology, 20(1), 46-50 (2018-09-19)
Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has
Simon J de Veer et al.
The Biochemical journal, 469(2), 243-253 (2015-05-20)
Laskowski inhibitors regulate serine proteases by an intriguing mode of action that involves deceiving the protease into synthesizing a peptide bond. Studies exploring naturally occurring Laskowski inhibitors have uncovered several structural features that convey the inhibitor's resistance to hydrolysis and
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持